This report provides exclusive insights into the COVID-19 impact on the Spinal Cord Stimulation Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Spinal Cord Stimulation Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Spinal Cord Stimulation Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on spinal
cord stimulation market provides an in-depth analysis of segments and sub-segments
in global as well as regional spinal cord stimulation market. The study also
highlights the impact of drivers, restraints and macro indicators on the global
and regional spinal cord stimulation market over the short term as well as long
term. The report is a comprehensive presentation of trends, forecast and dollar
values of global spinal cord stimulation market. According to a report the global
spinal cord stimulation market is projected to grow at a CAGR of 7.5% over the
forecast period of 2018-2024.
The spinal cord stimulation is a neuro stimulation therapy
used to treat a certain pain condition like chronic pain by blocking the pain
signals before they reach the brain with the help of spinal cord stimulators. A
spinal cord stimulator devices implanted under the patient's skin sends the
electric signals to the specific areas of spinal cords to treat the pain. When
the device is turned on, it modifies the pain signal before it reaches the
brain. A spinal cord stimulator device contains small wire that carries the
current (or electrical signals) and transmits it towards the nerve fibers of
the spinal cord.
According to WHO, around the world, between 250,000 and 500,000
people suffer from spinal cord injury (SCI) every year. The rising incidence of
spinal cord injuries, neurological disorder, and chronic back pain are the
sizable factors that drive the growth of the spinal cord stimulation market. In
addition, growing geriatric population, and rising demand for minimally
invasive surgeries also contributes towards the growth of the spinal cord
stimulation market. However, the high treatment cost and government regulations
are hampering the market growth. Moreover, ongoing research and development in
the spinal cord stimulation are expected to improve the market profitability
and able to serve more opportunities in upcoming years.
Geographically, North America accounted for the highest
share in the spinal cord stimulation market. In the North America region, the
prevalence of chronic back pain is more that creates the demand for spinal cord
stimulation among the population. According to the National Institute of
Neurological Disorder and Stroke, about 80 percent of adult’s experience low
back pain at any given time. In The U.S. 31 million people in the U.S.
experience lower back pain says American Chiropractic Association. The Asia-pacific
is expected to grow at the highest CAGR owing to the rising demand for minimal
intensive surgeries, improving healthcare infrastructure and healthcare
The report on global spinal cord stimulation market covers
segments such as products, application, and end user. On the basis of products, the global spinal cord stimulation market
is categorized into rechargeable and non-rechargeable. On the basis of application, the global spinal cord stimulation market
is categorized into failed back surgery syndrome, ischemic limb pain, complex
regional pain syndrome, and others. On the basis of end user the global spinal cord stimulation market is categorized into
clinics, hospitals and ambulatory surgical units.
The report provides regional analysis covering geographies such
as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period
of 2016-2024. The countries covered in the North America region include the
U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India,
South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain,
and Rest of Europe are included in the European region. The U.S. drives the
growth in the North America region as it is the largest market in the region.
The Asia-pacific region offers a substantial potential for the market growth
owing to rapid growth in markets such as India and China. The APAC region is
projected to experience a growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global
spinal cord stimulation market such as ST. JUDE MEDICAL, Boston, Medtronic,
Stimwave, Nevro, Greatbatch, and others.
The report provides deep insights on demand forecasts, market
trends, and micro and macro indicators. In addition, this report provides
insights into the factors that are driving and restraining the global spinal cord
stimulation market. Moreover, IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of spinal cord
stimulation market. Moreover, the study highlights current market trends and
provides forecast from 2018-2024. We also have highlighted future trends in the
spinal cord stimulation market that will impact the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings
an insight into the market share of the leading players. This report will help
manufacturers, suppliers, and distributors of the spinal cord stimulation market
to understand the present and future trends in this market and formulate their